Abstract:Importance Sulfamethoxazole (SMX) and cotrimoxazole (CTX), a fixed-dose combination of SMX and trimethoprim in a 5:1 ratio, are antibacterial sulfonamides commonly used for treating various diseases. A substantial prevalence of severe cutaneous adverse reactions (SCARs) following the administration of these drugs has been reported. However, the association between human leukocyte antigen (HLA) genotypes and SMX/CTX-induced SCARs has remained unclear. Objective To investigate the association between HLA genotypes and SMX/CTX-induced SCARs. Data sources A comprehensive search was conducted in CENTRAL (Cochrane Library), MEDLINE, and Embase from inception to January 17, 2023. Study Selection Case-control studies that recruited patients who had experienced SCARs following SMX or CTX were included, and HLA alleles were analyzed. Data Extraction and Synthesis Two independent authors extracted data on study characteristics and outcome data. The Meta-analysis of Observational Studies in Epidemiology ( MOOSE ) reporting guideline and the Preferred Reporting Items for Systematic Reviews and Meta-analyses ( PRISMA ) reporting guidelines were followed. The Newcastle-Ottawa Scale for case-control studies was used to assess study quality. Odds ratios (ORs) were calculated using a random-effects model for meta-analysis. Main Outcomes and Measures The prespecified outcome was the OR comparing SMX/CTX-induced SCARs with healthy or SMX/CTX-tolerant controls based on different HLA alleles. Results Six studies involving 322 patients with SCAR were included, including 236 patients with Stevens-Johnson syndrome/toxic epidermal necrolysis, 86 with drug reaction with eosinophilia and systemic symptoms, 8448 healthy controls, and 229 tolerant controls. Significant associations were found in HLA-A*11:01 (OR, 2.10; 95% CI, 1.11-4.00), HLA-B*13:01 (OR, 5.96; 95% CI, 1.58-22.56), HLA-B*15:02 (OR, 2.23; 95% CI, 1.20-4.14), HLA-B*38:02 (OR, 3.47; 95% CI, 1.42-8.48), and HLA-C*08:01 (OR, 2.63; 95% CI, 1.07-6.44) compared with tolerant controls. In the Stevens-Johnson syndrome/toxic epidermal necrolysis subgroup, significant associations were found in HLA-B*15:02 (OR, 3.01; 95% CI, 1.56-5.80) and HLA-B*38:02 (OR, 5.13; 95% CI, 1.96-13.47). In the drug reaction with eosinophilia and systemic symptoms subgroup, significant associations were found in HLA-A*68:01 (OR, 12.86; 95% CI, 1.09-151.34), HLA-B*13:01 (OR, 23.09; 95% CI, 3.31-161.00), HLA-B*39:01 (OR, 4.56; 95% CI, 1.31-15.82). Conclusions and Relevance The results of this systematic review and meta-analysis suggest that multiple HLA alleles ( HLA-A*11:01 , HLA-B*13:01, HLA-B*15:02, HLA-B*38:02, and HLA-C*0801 ) are associated with SMX/CTX-induced SCARs.

HLA-C*12:02 is Strongly Associated with Xuesaitong-induced Cutaneous Adverse Drug Reactions

Association Between HLA-B∗46:01 and Cutaneous Adverse Drug Reactions in Han Chinese

<i>HLA-A*02:01</i> allele is associated with tanshinone-induced cutaneous drug reactions in Chinese population

HLA-A*02:01 allele is associated with tanshinone-induced cutaneous drug reactions in Chinese population

HLA-A*02:07 Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients.

HLA-A*02 Alleles Are Associated with Tetanus Antitoxin-Induced Exanthematous Drug Eruptions in Chinese Patients.

The association between HLA-B variants and amoxicillin-induced severe cutaneous adverse reactions in Chinese han population

Association Study of Lamotrigine-Induced Cutaneous Adverse Reactions and HLA-B*1502 in a Han Chinese Population

Association Between HLA-A*3201 Allele and Oxcarbazepine-Induced Cutaneous Adverse Reactions in Eastern Han Chinese Population

Genetic Predictors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Aromatic Antiepileptic Drugs among the Chinese Han Population

Human Leukocyte Antigens and Sulfamethoxazole/Cotrimoxazole–Induced Severe Cutaneous Adverse Reactions

HLA Association with Drug-Induced Adverse Reactions

Strong Association Between HLA-B*1502 and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Mainland Han Chinese Patients

Hla-B*58:01 Allele is Associated with Augmented Risk for Both Mild and Severe Cutaneous Adverse Reactions Induced by Allopurinol in Han Chinese

Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans

Progress in Study on the Association Between HLA Genetic Variation and Adverse Drug Reactions.

Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China

HLA-A*24:02 is associated with metronidazole-induced cutaneous adverse drug reactions in Han Chinese individuals: a pilot case-control study with both HLA gene and T cell receptor repertoire analysis.

Hla-A*24:02 As A Common Risk Factor for Antiepileptic Drug-Induced Cutaneous Adverse Reactions

HLA-B*13:01 as a Risk Allele for Antiepileptic Drugs-Induced Cutaneous Adverse Reactions: Higher Risk for Cross-Reactivity?

994 Risk and Association of HLA Alleles with Methimazole Induced Cutaneous Adverse Reactions in Chinese Han Population